Patent · US Expired

Substituted aryl 1, 4-pyrazine derivatives

US7041672B2 · kind B2 · utility

56Cited by
0References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 12, 2004
Grant dateMay 9, 2006
Priority date
Expiry dateJun 15, 2024

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S206/828
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Substituted aryl pyrazine derivatives of the formula I as defined herein, and their use in treating anxiety disorders, depression and stress related disorders are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.